Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Fig 2

Research Article

Scolopendra subspinipes mutilans L. Koch Ameliorates Rheumatic Heart Disease by Affecting Relative Percentages of CD4+CD25+FoxP3 Treg and CD4+IL17 T Cells

Figure 2

Flow cytometry analysis of the percentage of CD4+CD25+FoxP3 Treg and CD4+IL-17 T cells in PBMCs. (a), the percentage of CD4+CD25+FoxP3 Treg cells in the CG group before placebo intervention. (b), the percentage of CD4+IL-17 T cells in the CG group before placebo intervention. (c), the percentage of CD4+CD25+ FoxP3 Treg cells in the SG group before SSLK intervention. (d), the percentage of CD4+IL-17 T cells in the SG group before SSLK intervention. (e), the percentage of CD4+CD25+FoxP3 Treg cells in the CG group after 3-month placebo intervention. (b), the percentage of CD4+IL-17 T cells in the CG group after 3-month placebo intervention. (c), the percentage of CD4+CD25+ FoxP3 Treg cells in the SG group after 3-month SSLK intervention. (d), the percentage of CD4+IL-17 T cells in the SG group after 3-month SSLK intervention. In the SG group, the patients took SSLK and in the CG group, the patients took placebo.

(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.